Login / Signup

Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML).

Brian J BallShukaib ArslanPaul KollerDat NgoMichelle AfkhamiAmandeep SalhotraMonzr M Al MalkiAhmed AribiHaris AliKaramjeet SandhuSalman OtoukeshIdoroenyi AmanamHoda Z PourhassanAndrew S ArtzPeter CurtinAnthony SteinRyotaro NakamuraGuido MarcucciEileen SmithVinod A PullarkatIbrahim Aldoss
Published in: Leukemia & lymphoma (2022)
Keyphrases
  • acute myeloid leukemia
  • newly diagnosed
  • allogeneic hematopoietic stem cell transplantation
  • chronic lymphocytic leukemia
  • acute lymphoblastic leukemia
  • diffuse large b cell lymphoma